References
- Zoroddua MA, Aaseth J, Crisponi G, Medici S, Peana M, Nurchi VM. The essential metals for humans: a brief overview. J Inorg Biochem 2019;195:120–9. doi: 10.1016/j.jinorgbio.2019.03.013
- Kodama H, Fujisawa C. Copper metabolism and inherited copper transport disorders: molecular mechanisms, screening, and treatment. Metallomics 2009;1:42–52. doi: 10.1039/B816011M
- Linder MC. Biochemistry of Copper. Biochemistry of the Elements, Vol. 10. New York: Springer Science+Business Media Series; 1991. doi: 10.1007/978-1-4757-9432-8
- Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, Dou QP, Franz KJ, Gohil VM, Gupta S, Kaler SG, Lutsenko S, Mittal V, Petris MJ, Polishchuk R, Ralle M, Schilsky ML, Tonks NK, Vahdat LT, Aelst LV, Xi D, Yuan P, Brady DC, Chang CJ. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer 2022;22:102–13. doi: 10.1038/s41568-021-00417-2
- Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: ‘Copper That Cancer’. Metallomics 2015;7:1459–76. doi: 10.1039/c5mt00149h
- Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther 2022;7(1):378. doi: 10.1038/s41392-022-01229-y
- Li Y. Copper homeostasis: Emerging target for cancer treatment. IUBMB Life 2020;72:1900–8. doi: 10.1002/iub.2341
- Viles JH. Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer’s, Parkinson’s and prion diseases. Coord Chem Rev 2012;256:2271–84. doi: 10.1016/j.ccr.2012.05.003
- Lanza V, Milardi D, Di Natale G, Pappalardo G. Repurposing of copper(II)-chelating drugs for the treatment of neurodegenerative diseases. Curr Med Chem 2018;25:525–39. doi: 10.2174/0929867324666170518094404
- Varnai VM, Blanuša M, Piasek M, Kostial K. New therapeutic and experimental aspects of chelators as antidotes of metal toxicity. Curr Med Chem 2009;4:130–82. doi: 10.2174/092986705774462987
- Kim J-J, Kim Y-S, Kumar V. Heavy metal toxicity: An update of chelating therapeutic strategies. J Trace Elem Med Biol 2019;54:226–31. doi: 10.1016/j.jtemb.2019.05.003
- Puentes-Díaz N, Chaparro D, Morales-Morales D, Flores-Gaspar A, Alí-Torres J. Role of metal cations of copper, iron, and aluminum and multifunctional ligands in Alzheimer’s disease: Experimental and computational insights. ACS Omega 2023;8:4508–26. doi: 10.1021/acsomega.2c06939
- Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer 2023;22:46. doi: 10.1186/s12943-023-01732-y
- Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, Wang J, Chen J, Li Y, Wang H. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updat 2024;72:101018. doi: 10.1016/j.drup.2023.101018
- Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol 2024;21:370–88. doi: 10.1038/s41571-024-00876-0
- Sampson EL, Jenagaratnam L, McShane R. Metal protein attenuating compounds for the treatment of Alzheimer’s dementia. Cochrane Database Syst Rev 2012;5(5):CD005380. doi: 10.1002/14651858.CD005380.pub4
- Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009;35:32–46. doi: 10.1016/j.ctrv.2008.07.004
- Falcone E, Okafor M, Vitale N, Raibaut L, Sour A, Faller P. Extracellular Cu2+ pools and their detection: From current knowledge to next-generation probes. Coord Chem Rev 2021;433:213727. doi: 10.1016/j.ccr.2020.213727
- Kirsipuu T, Zadorožnaja A, Smirnova J, Friedemann M, Plitz T, Tõugu V, Palumaa P. Copper(II)-binding equilibria in human blood. Sci Rep 2020;10(1):5686. doi: 10.1038/s41598-020-62560-4
- Neumann PZ, Sass-Kortsak A. The state of copper in human serum: Evidence for an amino acid-bound fraction. J Clin Invest 1967;46:646–58. doi: 10.1172/JCI105566
- Sarkar B, Kruck TPA. Separation of Cu(II) – amino acid complexes and evidence for the existence of histidine–Cu(II)–glutamate and histidine–Cu(II)–serine complexes at physiological pH. Can J Biochem 1967;45:2046–9. doi: 10.1139/o67-238
- Sarkar B, Wigfield Y. Evidence for albumin – Cu(II) – amino acid ternary complex. Can J Biochem 1968;46:601–7. doi: 10.1139/o68-092
- Lau S-J, Sarkar B. Ternary coordination complex between human serum albumin, copper(II), and
l -histidine. J Biol Chem 1971;246:5938–43. doi: 10.1016/S0021-9258(18)61817-4 - Deschamps P, Kulkarni PP, Gautam-Basak M, Sarkar B. The saga of copper(II)–
l -histidine. Coord Chem Rev 2005;249:895–909. doi: 10.1016/j.ccr.2004.09.013 - Sarkar B. Treatman of Wilson and Menkes diseases. Chem Rev 1999;99:2535–44. doi: 10.1021/cr980446m
- Kaler SG. Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment. J Trace Elem Med Biol 2014;28:427–30. doi: 10.1016/j.jtemb.2014.08.008
- Harford C, Sarkar B. Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) motif of proteins and peptides: Metal binding, DNA cleavage, and other properties. Acc Chem Res 1997;30:123–30. doi: 10.1021/ar9501535
- Linder MC. Ceruloplasmin and other copper binding components of blood plasma and their functions: An update. Metallomics 2016;8:887–905. doi: 10.1039/c6mt00103c
- Darwish HM, Cheney JC, Schmitt RC, Ettinger MJ. Mobilization of copper(II) from plasma components and mechanisms, of hepatic copper transport. Am J Physiol 1984;246:G72–9. doi: 10.1152/ajpgi.1984.246.1.G72
- Bartnicka JJ, Al-salemee F, Firth G, Blower PJ.
l -Cysteine-mediated modulation of copper trafficking in prostate cancer cells: An in vitro and in vivo investigation with 64Cu and 64Cu-PET. Metallomics 2020;12:1451–618. doi: 10.1039/d0mt00161a - Mesu JG, Visser T, Soulimani F, van Faassen EE, de Peinder P, Beale AM, Weckhuysen BM. New insights into the coordination chemistry and molecular structure of copper(II) histidine complexes in aqueous solutions. Inorg Chem 2006;45:1960–71. doi: 10.1021/ic051305n
- Romanelli M, Basosi R. An electron spin-echo study of Cu(II)-(His)n in frozen aqueous solution. Chem Phys Lett 1988;143:404–8. doi: 10.1016/0009-2614(88)87056-8
- Valensin G, Basosi R, Antholine WE, Gaggeli E. Structural, motional, and kinetic features of the Cu(II)-(
l -His)2 complex in aqueous solution. J Inorg Biochem 1985;23:125–30. doi: 10.1016/0162-0134(85)83016-6 - Szabó-Plánka T, Rockenbauer A, Korecz L, Nagy D. An electron spin resonance study of coordination modes in the copper(II)–histamine and copper(II)–
l -histidine systems in fluid aqueous solution. Polyhedron 2000;19:1123–31. doi: 10.1016/S0277-5387(00)00364-8 - Shtyrlin VG, Zyavkina YI, Gilyazetdinov EM, Bukharov MS, Krutikov AA, Garipov RR, Mukhtarov AS, Zakharov AV. Complex formation, chemical exchange, species structure, and stereoselective effects in the copper(II)-
l /dl -histidine systems. Dalton Trans 2012;41:1216–28. doi: 10.1039/c1dt11309g - Pan Y, Zhang LY, Liu YZ. XAFS study of coordination structure of Cu(L-His)2 in solution. Chin J Chem Phys 2011;24:451–6. doi: 10.1088/1674-0068/24/04/451-456
- Cocetta P, Deiana S, Erre L, Micerat C, Piu P. Spectroscopic analysis of binary and ternary copper(II) complexes formed by histidine and glutamic acid. J Coord Chem 1983;12:213–8. doi: 10.1080/00958978308073851
- Deschamps P, Zerrouk N, Martens T, Charlot M-F, Girerd JJ, Chaumeil JC, Tomas A. Copper complexation by amino acid:
l -glutamine–copper(II)–l -histidine ternary system. J Trace Microprobe Tech 2003;21:729–41. doi: 10.1081/TMA-120025823 - Marković M, Ramek M, Sabolović J. Why does the coordination mode of physiological bis(
l -histidinato)copper(II) differ in the gas phase, crystal lattice, and aqueous solutions? A quantum chemical study. Eur J Inorg Chem 2014;1:198–212. doi: 10.1002/ejic.201300746 - Sabolović J, Ramek M, Marković M. Calculating the geometry and Raman spectrum of physiological bis(
l -histidinato)copper(II): an assessment of DFT functionals for aqueous and isolated systems. J Mol Model 2017;23(10):290. doi: 10.1007/s00894-017-3448-z - Marković M, Ramek M, Loher C, Sabolović J. The important role of the hydroxyl group on the conformational adaptability in bis(
l threoninato)copper(II) compared to bis(l -allo-threoninato)copper(II): Quantum chemical study. Inorg Chem 2016;55:7694–708. doi: 10.1021/acs.inorgchem.6b01157 - Ramek M, Marković M, Mutapčić I, Pejić J, Kelterer A-M, Sabolović J. Conformational analyses of physiological binary and ternary copper(II) complexes with
l -asparagine andl -histidine; Study of tridentate binding of copper(II) in aqueous solution. ChemistryOpen 2019;8:852–68. doi: 10.1002/open.201900159 - Ramek M, Sabolović J. Structure prediction of physiological bis(amino acidato)copper(II) species in aqueous solution: The copper(II) compounds with
l -glutamine andl -histidine. J Inorg Biochem 2024;251:112430. doi: 10.1016/j.jinorgbio.2023.112430 - Ramek M, Pejić J, Sabolović J. Structure prediction of neutral physiological copper(II) compounds with
l -cysteine andl -histidine. J Inorg Biochem 2021;223:111536. doi: 10.1016/j.jinorgbio.2021.111536 - Ramek M, Marković M, Loher C, Sabolović J. Pronounced conformational flexibility of physiological (
l -histidinato)(l -threoninato) copper(II) in aqueous solution disclosed by a quantum chemical study. Polyhedron 2017;135:121–33. doi: 10.1016/j.poly.2017.06.041 - Cramer CJ, Truhlar DG. Density functional theory for transition metals and transition metal chemistry. Phys Chem Chem Phys 2009;11:10757–816. doi: 10.1039/b907148b
- Summers KL, Roseman GP, Sopasis GJ, Millhauser GL, Harris HH, Pickering IJ, George GN. Copper(II) binding to PBT2 differs from that of other 8-hydroxyquinoline chelators: Implications for the treatment of neurodegenerative protein misfolding diseases. Inorg Chem 2020;59:17519–34. doi: 10.1021/acs.inorgchem.0c02754
- Sgarlata C, Arena G, Bonomo RP, Giuffrida A, Tabbì G. Simple and mixed complexes of copper(II) with 8-hydroxyquinoline derivatives and amino acids: Characterization in solution and potential biological implications. J Inorg Biochem 2018;180:89–100. doi: 10.1016/j.jinorgbio.2017.12.002
- VanBriesen JM, Small M, Weber C, Wilson J. Modelling chemical speciation: thermodynamics, kinetics and uncertainty. In: Hanrahan G, editor. Modelling of pollutants in complex environmental systems. Hertfordshire: ILM Publications; 2010. p. 35–148.
- Hallman PS, Perrin DD, Watt E. The computed distribution of copper(II) and zinc(II) ions among seventeen amino acids present in human blood plasma. Biochem J 1971;121:549–55. doi: 10.1042/bj1210549
- Berthon G, Blais M-J, Piktas M, Houngbossa K. Trace metal requirements in total parenteral nutrition (TPN): 5. Formation constants for the copper(II)-histidine ternary complexes with threonine, lysine, glycine, phenylalanine, valine, and cystine, and discussion of their implications regarding the copper distribution in blood plasma during TPN and the evaluation of the daily dose of copper. J Inorg Biochem 1984;20:113–30. doi: 10.1016/0162-0134(84)80012-4
- Cole A, Furnival C, Huang Z-X, Jones DC, May PM, Smith GL, Whittaker J, Williams DR. Computer simulation models for the low-molecular-weight complex distribution of cadmium(II) and nickel(II) in human blood plasma. Inorg Chim Acta 1985;108:165–71. doi: 10.1016/S0020-1693(00)84536-3
- Berthon G, Hacht B, Blais M-J, May PM. Copper-histidine ternary complex equilibria with glutamine, asparagine and serine. The implications for computer-simulated distributions of copper(II) in blood plasma. Inorg Chim Acta 1986;125:219–27. doi: 10.1016/S0020-1693(00)81215-3
- Brumas V, Alliey N, Berthon G. A new investigation of copper(II)-serine, copper(II)-histidine-serine, copper(II)-asparagine, and copper(II)-histidine-asparagine equilibria under physiological conditions, and implications for simulation models relative to blood plasma. J Inorg Biochem 1993;52:287–96. doi: 10.1016/0162-0134(93)80032-5
- Tran-Ho L-C, May PM, Hefler GT. Complexation of copper(I) by thioamino acids implications for copper speciation in blood plasma cystein. J Inorg Biochem 1997;68:225–31. doi: 10.1016/S0162-0134(97)00097-4
- Königsberger L-C, Königsberger E, Hefter G, May PM. Formation constants of copper(I) complexes with cysteine, penicillamine and glutathione: implications for copper speciation in the human eye. Dalton Trans 2015;44:20413–25. doi: 10.1039/c5dt02129d
- May PM. JESS at thirty: Strengths, weaknesses and future needs in the modelling of chemical speciation. Appl Geochem 2015;55:3–16. doi: 10.1016/j.apgeochem.2014.11.023
- Berthon G. Critical evaluation of the stability constants of metal complexes of amino acids with polar side chains. Pure Appl Chem 1995;67:1117–240. doi: 10.1351/pac199567071117
- Rigo A, Corazza A, di Paolo ML, Rossetto M, Ugolini R, Scarpa M. Interaction of copper with cysteine: stability of cuprous complexes and catalytic role of cupric ions in anaerobic thiol oxidation. J Inorg Biochem 2004;98:1495–501. doi: 10.1016/j.jinorgbio.2004.06.008
- Mlakar M, Pavković S, Tumir L-M, Vukosav P, Gašparović B. Characterization of biochemically active Cu(II) mixed ligand complex with histidine and cysteine. Electroanalysis 2017;29:392–7. doi: 10.1002/elan.201600253
- Pinto LD, Puppin PAL, Behring VM, Flinker DH, Mercê ALR, Mangrich AS, Rey NA, Felcman J. Solution and solid state study of copper(II) ternary complexes containing amino acids of interest for brain biochemistry – 1: Aspartic or glutamic acids with methionine or cysteine. Inorg Chim Acta 2010;363:2624–30. doi: 10.1016/j.ica.2010.04.036
- Harris WR, Sammons RD, Grabiak RC. A speciation model of essential trace metal ions in phloem. J Inorg Biochem 2012;116:140–50. doi: 10.1016/j.jinorgbio.2012.07.011
- Cruzat V, Rogero MM, Keane KN, Curi R, Newsholme P. Glutamine: Metabolism and immune function, supplementation and clinical translation. Nutrients 2018;10(11):1564. doi: 10.3390/nu10111564
- Dokmanić I, Šikić M, Tomić S. Metals in proteins: correlation between the metal-ion type, coordination number and the amino-acid residues involved in the coordination. Acta Crystallogr D Biol Crystallogr 2008;64:257–63. doi: 10.1107/S090744490706595X
- Rubino JT, Franz KJ. Coordination chemistry of copper proteins: How nature handles a toxic cargo for essential function. J Inorg Biochem 2012;107:129–43. doi: 10.1016/j.jinorgbio.2011.11.024
- Sabolović J, Liedl KR. Why are copper(II) amino acid complexes not planar in their crystal structures? An ab initio and molecular mechanics study. Inorg Chem 1999;38:2764–74. doi: 10.1021/ic980471a
- Sabolović J, Tautermann CS, Loerting T, Liedl KR. Modeling anhydrous and aqua copper(II) amino acid complexes: A new molecular mechanics force field parametrization based on quantum chemical studies and experimental crystal data. Inorg Chem 2003;42:2268–79. doi: 10.1021/ic025967d
- Halcrow MA. Jahn–Teller distortions in transition metal compounds, and their importance in functional molecular and inorganic materials. Chem Soc Rev 2013;42:1784–95. doi: 10.1039/C2CS35253B
- Williams DR. Thermodynamic considerations in co-ordination. Part X. A potentiometric and calorimetric investigation of copper(II) histidine complexes. J Chem Soc Dalton Trans 1972;7:790–7. doi: 10.1039/DT9720000790
- Szabó-Plánka T, Rockenbauer A, Györ M, Gaizer F. ESR study of copper(II) complexes of α-amino acids. Coordination modes and metal-ligand bonds in frozen aqueous solutions. J Coord Chem 1988;17:69–83. doi: 10.1080/00958978808078449
- Gergely A, Nagypál I, Farkas E. Thermodynamic relations of parent and mixed complexes of asparagine and glutamine with copper(II). J Inorg Nucl Chem 1975;37:551–5. doi: 10.1016/0022-1902(75)80371-X
- Noethig-Laslo V, Paulić N. Comparative EPR study of copper(II) complexes with threonine derivatives. Monatsh Chem 1997;128:1101–8. doi: 10.1007/BF00807560
- Baxter AC, Williams DR. Thermodynamic considerations in coordination. Part XXI. Structures of copper(II)–asparaginate, – histidinate, and – threoninate ternary complexes in aqueous solution. J Chem Soc Dalton 1975;18:1757–61. doi: 10.1039/DT9750001757
- Deschamps P, Kulkarni PP, Sarkar B. X-ray structure of physiological copper(II)–bis(
l -histidinato) complex. Inorg Chem 2004;43:3338–40. doi: 10.1021/ic035413q - Freeman HC, Guss JM, Healy MJ, Martin R-P, Nockolds CE, Sarkar B. The structure of a mixed amino-acid complex:
l -histidinato-l -threoninatoaquocopper(II) hydrate. J Chem Soc D 1969;5:225–6. doi: 10.1039/C29690000225 - Ono T, Shimanouchi H, Sasada Y, Sakurai T, Yamauchi O, Nakahara A. Crystal structures of mixed ligand copper(II) complexes containing
l -amino acids. I.l -Asparaginato-l -histidinato-copper(II) and its hydrate. Bull Chem Soc Jpn 1979;52:2229–34. doi: 10.1246/bcsj.52.2229 - Murphy JM, Powell BA, Brumaghim JL. Stability constants of bio-relevant, redox-active metals with amino acids: The challenges of weakly binding ligands. Coord Chem Rev 2020;412:213253. doi: 10.1016/j.ccr.2020.213253
- Kayalis A, Berthon G. Histamine as a ligand in blood plasma - II: Stability constants for its ternary complexes of Cu(II) with
l -histidine,l -glutamine andl -threonine. Polyhedron 1982;1:371–6. doi: 10.1016/S0277-5387(00)80822-0 - Kruck TPA, Sarkar B. Ternary coordination complexes between copper(II) and amino acids, and an appraisal of the enhancement of ternary complex stability. Can J Chem 1973;51:3555–62. doi: 10.1139/v73-530
- Yamauchi O, Sakurai T, Nakahara A. Histidine-containing ternary amino acid-copper(II) complexes syntheses and properties. J Am Chem Soc 1979;101:4164–72. doi: 10.1021/ja00509a024
- Cerda BA, Wesdemiotis C. The relative copper(I) ion affinities of amino acids in the gas phase. J Am Chem Soc 1995;117:9734–9. doi: 10.1021/ja00143a017
- Hoyau S, Ohanessian G. Absolute affinities of α-amino acids for Cu+ in the gas phase. A theoretical study. J Am Chem Soc 1997;119:2016–24. doi: 10.1021/ja963432b
- Belcastro M, Marino T, Russo N, Toscano M. Interaction of cysteine with Cu2+ and group IIb (Zn2+, Cd2+, Hg2+) metal cations: a theoretical study. J Mass Spectrom 2005;40:300–6. doi: 10.1002/jms.755
- Grimme S, Antony J, Ehrlich S, Krieg H. A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J Chem Phys 2010;132(15):154104. doi: 10.1063/1.3382344
- Scalmani G, Frisch MJ. Continuous surface charge polarizable continuum models of solvation. I. General formalism. J Chem Phys 2010;132:114110. doi: 10.1063/1.3359469
- Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich AV, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery JA, Jr., Peralta JE, Ogliaro F, Bearpark MJ, Heyd JJ, Brothers EN, Kudin KN, Staroverov VN, Keith TA, Kobayashi R, Normand J, Raghavachari K, Rendell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ. Gaussian 16 (Revision C.01). Gaussian, Inc., Wallingford CT, 2019.
- Fernández-Ramos A, Cabaleiro-Lago E, Hermida-Ramón JM, Martínez-Núñez E, Peña-Gallego. DFT conformational study of cysteine in gas phase and aqueous solution. J Mol Struct - Theochem 2000;498:191–200. doi: 10.1016/S0166-1280(99)00261-4